BEXAROTENE
Generic: BEXAROTENE
Amneal Pharmaceuticals NY LLCManufacturer
ORALRoute
BEXAROTENEActive Substance
2018-09-04Original Approval
BEXAROTENE is FDA application ANDA210105, sponsored by AMNEAL PHARMS NY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
90 reports
2
OFF LABEL USE
56 reports
3
DISEASE PROGRESSION
39 reports
4
DEATH
34 reports
5
PRURITUS
25 reports
6
PRODUCT USE IN UNAPPROVED INDICATION
23 reports
7
CUTANEOUS T-CELL LYMPHOMA
21 reports
8
FATIGUE
21 reports
9
MALIGNANT NEOPLASM PROGRESSION
19 reports
10
CONDITION AGGRAVATED
18 reports